Possible involvement of soluble B7-H4 in T cell-mediated inflammatory immune responses

Biochemical and Biophysical Research Communications

Volumn 389, Issue 2, 2009, Pages 349-353

  Kamimura, Yosuke ^a   Kobori, Hiroko ^a   Piao, Jinhua ^a   Hashiguchi, Masaaki ^a   Matsumoto, Koichiro ^b   Hirose, Sachiko ^c   Azuma, Miyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

B7 family; Contact hypersensitivity; Costimulation; Mouse; T cells

Indexed keywords

B7 ANTIGEN; B7 H4 ANTIGEN; GAMMA INTERFERON; HAPTEN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EAR DISEASE; EDEMA; FEMALE; GENETIC TRANSCRIPTION; INFLAMMATION; LUPUS VULGARIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIZATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD80; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INFLAMMATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

MUS;

EID: 70349325495     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.144     Document Type: Article

References (25)

1. Prasad D.V., Richards S., Mai X.M., and Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18 (2003) 863-873
2. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., and Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18 (2003) 849-861
3. Zang X., Loke P., Kim J., Murphy K., Waitz R., and Allison J.P. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA 100 (2003) 10388-10392
4. Suh W.K., Wang S., Duncan G.S., Miyazaki Y., Cates E., Walker T., Gajewska B.U., Deenick E., Dawicki W., Okada H., Wakeham A., Itie A., Watts T.H., Ohashi P.S., Jordana M., Yoshida H., and Mak T.W. Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol. Cell. Biol. 26 (2006) 6403-6411
5. Zhu G., Augustine M.M., Azuma T., Luo L., Yao S., Anand S., Rietz A.C., Huang J., Xu H., Flies A.S., Flies S.J., Tamada K., Colonna M., van Deursen J.M., and Chen L. B7-H4 deficient mice display augmented neutrophil-mediated innate immunity. Blood 113 (2008) 1756-1767
6. Salceda S., Tang T., Kmet M., Munteanu A., Ghosh M., Macina R., Liu W., Pilkington G., and Papkoff J. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp. Cell Res. 306 (2005) 128-141
7. Tringler B., Zhuo S., Pilkington G., Torkko K.C., Singh M., Lucia M.S., Heinz D.E., Papkoff J., and Shroyer K.R. B7-H4 is highly expressed in ductal and lobular breast cancer. Clin. Cancer Res. 11 (2005) 1842-1848
8. Krambeck A.E., Thompson R.H., Dong H., Lohse C.M., Park E.S., Kuntz S.M., Leibovich B.C., Blute M.L., Cheville J.C., and Kwon E.D. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc. Natl. Acad. Sci. USA 103 (2006) 10391-10396
9. Sun Y., Wang Y., Zhao J., Gu M., Giscombe R., Lefvert A.K., and Wang X. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 53 (2006) 143-151
10. Zang X., Thompson R.H., Al-Ahmadie H.A., Serio A.M., Reuter V.E., Eastham J.A., Scardino P.T., Sharma P., and Allison J.P. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc. Natl. Acad. Sci. USA 104 (2007) 19458-19463
11. Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., Brumlik M., Cheng P., Curiel T., Myers L., Lackner A., Alvarez X., Ochoa A., Chen L., and Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203 (2006) 871-881
12. Simon I., Zhuo S., Corral L., Diamandis E.P., Sarno M.J., Wolfert R.L., and Kim N.W. B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res. 66 (2006) 1570-1575
13. Thompson R.H., Zang X., Lohse C.M., Leibovich B.C., Slovin S.F., Reuter V.E., Cheville J.C., Blute M.L., Russo P., Kwon E.D., and Allison J.P. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res. 68 (2008) 6054-6058
14. Nosaka T., Kawashima T., Misawa K., Ikuta K., Mui A.L., and Kitamura T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18 (1999) 4754-4765
15. Youngnak P., Kozono Y., Kozono H., Iwai H., Otsuki N., Jin H., Omura K., Yagita H., Pardoll D.M., Chen L., and Azuma M. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem. Biophys. Res. Commun. 307 (2003) 672-677
16. Hashiguchi M., Kobori H., Ritprajak P., Kamimura Y., Kozono H., and Azuma M. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc. Natl. Acad. Sci. USA 105 (2008) 10495-10500
17. Kamimura Y., Iwai H., Piao J., Hashiguchi M., and Azuma M. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. J. Immunol. 182 (2009) 2708-2716
18. Piao J., Kamimura Y., Iwai H., Cao Y., Kikuchi K., Hashiguchi M., Masunaga T., Jiang H., Tamura K., Sakaguchi S., and Azuma M. Enhancement of T cell-mediated anti-tumor immunity via the ectopically expressed glucocorticoid-induced tumor necrosis factor receptor-related receptor ligand (GITRL) on tumors. Immunology 127 (2009) 489-499
19. Ebata T., Mogi S., Hata Y., Fujimoto J.I., Yagita H., Okumura K., and Azuma M. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation. Eur. J. Immunol. 31 (2001) 1410-1416
20. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145 (1991) 185-192
21. Kayagaki N., Yamaguchi N., Nagao F., Matsuo S., Maeda H., Okumura K., and Yagita H. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94 (1997) 3914-3919
22. Nakajima A., Watanabe N., Yoshino S., Yagita H., Okumura K., and Azuma M. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol. 9 (1997) 637-644
23. Iwai H., Kozono Y., Hirose S., Akiba H., Yagita H., Okumura K., Kohsaka H., Miyasaka N., and Azuma M. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J. Immunol. 169 (2002) 4332-4339
24. Iwai H., Abe M., Hirose S., Tsushima F., Tezuka K., Akiba H., Yagita H., Okumura K., Kohsaka H., Miyasaka N., and Azuma M. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol. 171 (2003) 2848-2854
25. Matsumoto K., Inoue H., Nakano T., Tsuda M., Yoshiura Y., Fukuyama S., Tsushima F., Hoshino T., Aizawa H., Akiba H., Pardoll D., Hara N., Yagita H., Azuma M., and Nakanishi Y. B7-DC regulates asthmatic response by an IFN-γ-dependent mechanism. J. Immunol. 172 (2004) 2530-2541